Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.

MLA

Vassal, G., et al. “Therapeutic Activity of CPT-11, a DNA-Topoisomerase I Inhibitor, against Peripheral Primitive Neuroectodermal Tumour and Neuroblastoma Xenografts.” British Journal of Cancer, vol. 74, no. 4, Aug. 1996, pp. 537–45. EBSCOhost, https://doi.org/10.1038/bjc.1996.398.

APA

Vassal, G., Terrier-Lacombe, M., Bissery, M., Vénuat, A., Gyergyay, F., Bénard, J., Morizet, J., Boland, I., Ardouin, P., Bressac-de-Paillerets, B., Gouyette, A., Terrier-Lacombe, M. J., Bissery, M. C., Vénuat, A. M., & Bénard, J. (1996). Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts. British Journal of Cancer, 74(4), 537–545. https://doi.org/10.1038/bjc.1996.398

Chicago

Vassal, G, Mj Terrier-Lacombe, Mc Bissery, Am Vénuat, F Gyergyay, J Bénard, J Morizet, et al. 1996. “Therapeutic Activity of CPT-11, a DNA-Topoisomerase I Inhibitor, against Peripheral Primitive Neuroectodermal Tumour and Neuroblastoma Xenografts.” British Journal of Cancer 74 (4): 537–45. doi:10.1038/bjc.1996.398.